1.Value of chromosomal microarray analysis for the diagnosis of fetuses with anomalies of central nervous system.
Peixuan CAO ; Xiangyu ZHU ; Leilei GU ; Wei LIU ; Jie LI
Chinese Journal of Medical Genetics 2023;40(2):181-185
OBJECTIVE:
To assess the value of chromosomal microarray analysis (CMA) for the diagnosis of fetuses with anomalies of the central nervous system (CNS) and summarize the outcome of the pregnancies and follow-up.
METHODS:
A total of 636 fetuses from June 2014 to December 2020 who were referred to the Prenatal Diagnosis Center of Nanjing Drum Tower Hospital due to abnormal CNS prompted by ultrasound were selected as the research subjects. Based on the ultrasound findings, the fetuses were divided into ventricular dilatation group (n = 441), choroid plexus cyst group (n = 41), enlarged posterior fossa group (n = 42), holoprosencephaly group (n = 15), corpus callosum hypoplasia group (n = 22), and other anomaly group (n = 75). Meanwhile, they were also divided into isolated (n = 504) and non-isolated (n = 132) groups based on the presence of additional abnormalities. Prenatal samples (amniotic fluid/chorionic villi/umbilical cord blood) or abortus tissue were collected for the extraction of genomic DNA and CMA assay. Outcome of the pregnancies and postnatal follow-up were summarized and subjected to statistical analysis.
RESULTS:
In total 636 fetuses with CNS anomalies (including 89 abortus tissues) were included, and 547 cases were followed up. The overall detection rate of CMA was 11.48% (73/636). The detection rates for the holoprosencephaly group, ACC group, choroid plexus cyst group, enlarged posterior fossa group, ventricular dilatation group and other anomaly group were 80% (12/15), 31.82% (7/22), 19.51% (8/41), 14.29% (6/42), 7.48% (33/441) and 9.33% (7/75), respectively. Compared with the isolated CNS anomaly group, the detection rate for the non-isolated CNS anomaly group was significantly higher (6.35% vs. 31.06%) (32/504 vs. 41/132) (χ² = 62.867, P < 0.001). Follow up showed that, for 52 fetuses with abnormal CMA results, 51 couples have opted induced labor, whilst 1 was delivered at full term with normal growth and development. Of the 434 fetuses with normal CMA results, 377 were delivered at full term (6 had developmental delay), and 57 couples had opted induced labor. The rate of adverse pregnancy outcome for non-isolated CNS abnormal fetuses was significantly higher than that of isolated CNS abnormal fetuses (26.56% vs. 10.54%) (17/64 vs. 39/370) (χ² = 12.463, P < 0.001).
CONCLUSION
Fetuses with CNS anomaly should be tested with CMA to determine the genetic cause. Most fetuses with negative CMA result have a good prognosis, but there is still a possibility for a abnormal neurological phenotype. Fetuses with CNS abnormalities in conjunct with other structural abnormalities are at increased risk for adverse pregnancy outcomes.
Female
;
Pregnancy
;
Humans
;
Holoprosencephaly
;
Prenatal Diagnosis/methods*
;
Central Nervous System
;
Fetus/abnormalities*
;
Nervous System Malformations/genetics*
;
Microarray Analysis
;
Central Nervous System Diseases
;
Cysts
;
Chromosome Aberrations
;
Ultrasonography, Prenatal/methods*
3.A cohort study of vincristine-induced peripheral neuropathy in children.
Chuang LI ; Jiao JIN ; Jing HUANG ; Xiao-Yan YANG ; Yan LI ; Yong-Yan YAN ; Can YANG
Chinese Journal of Contemporary Pediatrics 2023;25(5):470-475
OBJECTIVES:
To study the characteristics of vincristine-induced peripheral neuropathy (VIPN) in children with acute lymphoblastic leukemia (ALL) and the factors influencing the development of VIPN.
METHODS:
The children with ALL, aged 1-18 years, who were treated with CCCG-ALL2015 or CCCG-ALL2020 regimen in the Affiliated Hospital of Guizhou Medical University from January 2018 to February 2022 were enrolled as subjects. According to the influence of age on risk, the children were divided into 1-10 years group with 91 children and >10 years group with 29 children. VIPN was graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (5th edition), and the incidence rate, severity, and type of VIPN were compared between different groups.
RESULTS:
A total of 120 children were enrolled in this study, among whom 56 (46.7%) developed VIPN. The >10 years group had a significantly higher incidence rate of VIPN than the 1-10 years group (69% vs 40%, P<0.05). Among the 56 children with VIPN, 12 (21%) had grade 3 VIPN or above, and 44 (79%) had grade 2 VIPN. There were 77 cases of autonomic nerve symptoms (59.7%), 42 cases of peripheral nerve injury (32.5%), and 10 cases of cranial nerve injury (7.8%). There were no significant differences in the severity and type of VIPN between the groups with different ages, sexes, degrees of risk, or treatment regimens (P>0.05). The results of binary logistic regression analysis showed that age is the influencing factor for the occurrence of VIPN (P>0.05).
CONCLUSIONS
There is a relatively high incidence rate of VIPN in children with ALL, with the highest incidence rate of autonomic nervous symptoms. The incidence of VIP in children over 10 years old is relatively high.
Child
;
Humans
;
Antineoplastic Agents, Phytogenic/adverse effects*
;
Cohort Studies
;
Peripheral Nervous System Diseases/diagnosis*
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy*
;
Vincristine/adverse effects*
;
Infant
;
Child, Preschool
;
Adolescent
4.Retrospective Analysis of Pathological Diagnosis of Central Nervous System Diseases in Tibet.
Han-Huan LUO ; Qian WANG ; Bula DUO ; Zhen HUO
Acta Academiae Medicinae Sinicae 2022;44(1):24-29
Objective To analyze the disease spectrum and clinicopathological characteristics of central nervous system(CNS)diseases diagnosed based on pathological findings in Tibet. Methods We collected the data of all the cases with CNS lesions in Tibet Autonomous Region People's Hospital from January 2013 to December 2020.The clinicopathological features were analyzed via light microscopy,immunohistochemical staining,and special staining. Results A total of 383 CNS cases confirmed by pathological diagnosis were enrolled in this study,with a male-to-female ratio of 188∶195 and an average age of(40.03±17.39)years(0-74 years).Among them,127(33.2%)cases had non-neoplastic diseases,with a male-to-female ratio of 82∶45 and an average age of(31.99±19.29)years;256(66.8%)cases had neoplastic diseases,with a male-to-female ratio of 106∶150 and an average age of(44.01±14.87)years.The main non-neoplastic diseases were nervous system infectious diseases,cerebral vascular diseases,meningocele,cerebral cyst,and brain trauma.Among the infectious diseases,brain abscess,granulomatous inflammation,cysticercosis,and hydatidosis were common.The main neoplastic diseases included meningioma,pituitary adenoma,neuroepithelial tumor,schwannoma,metastatic tumor,and hemangioblastoma.The meningioma cases consisted of 95.4%(103/108)cases of grade Ⅰ,3.7%(4/108)cases of grade Ⅱ,and only 1(1/108,0.9%)case of grade Ⅲ.Among the neuroepithelial tumor cases,the top three were glioblastoma,grade Ⅲ diffuse glioma,and ependymoma. Conclusions There are diverse CNS diseases confirmed by pathological diagnosis in Tibet,among which non-neoplastic diseases account for 1/3 of all the cases.Infectious and vascular diseases are the most common non-neoplastic diseases in Tibet,and tuberculosis and parasitic infections are relatively common.The types and proportion of brain tumors in Tibet are different from those in other regions of China,and meningioma is the most common in Tibet,with higher proportion than neuroepithelial tumor.
Adolescent
;
Adult
;
Aged
;
Brain Neoplasms/diagnosis*
;
Central Nervous System Diseases/pathology*
;
Child
;
Child, Preschool
;
Ependymoma
;
Female
;
Humans
;
Infant
;
Infant, Newborn
;
Male
;
Meningeal Neoplasms
;
Middle Aged
;
Retrospective Studies
;
Tibet/epidemiology*
;
Young Adult
5.Evaluation of the implementation of Diagnostic Criteria of Occupational Acute Neurotoxic Diseases Caused by Chemicals (GBZ 76-2002).
Ji WANG ; Li SONG ; Dong Mei SHI ; Hai Liang ZOU ; Dan Dan LI ; Qiu Hong ZHU
Chinese Journal of Industrial Hygiene and Occupational Diseases 2022;40(10):742-746
Objective: To investigate the implementation of Diagnostic Criteria of Occupational Acute Neurotoxic Diseases Caused by Chemicals (GBZ 76-2002) for accumulating basis of standard revision. Methods: In February 2020, 85 experts in occupational diseases and neurology from 39 medical and health institutions were selected as the respondents. The modified Delphi method was used to establish the standard evaluation index system and special group was organized for discussing the pre-survey and completing the questionnaire survey. Questionnaire survey was performed to investigate the grasp of the standards, application and modification suggestions of respondents. Results: The respondents' mastery of standard-related knowledge mainly came from work experience (84.7%, 72/85) , standard learning (81.2%, 69/85) and training (75.3%, 64/85) . Among the institutions in which the respondents worked, 98.8% (84/85) could carry out CT examinations, 96.5% (82/85) could carry out nerve conduction velocity and electromyography examinations, 89.4% (76/85) could carry out EEG examinations, 80% (68/85) could carry out evoked potential examinations and 72.9% (62/85) could carry out MRI examinations. Among the toxicants diagnosed as occupational acute toxic myelopathy, 10.6% (9/85) were organic phosphorus and 9.4% (8/85) were asphyxiating gas; Among the toxicants diagnosed as delayed peripheral neuropathy, pesticides accounted for 25.9% (22/85) and asphyxiating gases accounted for 12.9% (11/85) . 85.9% (73/85) of the respondents believed that the basis for the classification of acute toxic encephalopathy needed to supplement objective evidence; 80.0% (68/85) of the respondents thought that the diagnosis and classification of peripheral neuropathy should be refined according to the abnormal indexes of neuroelectromyography. Conclusion: The applicability of the criteria needs to be improved because the current criteria has a long application cycle without enough objective investigation bases in classification criteria index.
Humans
;
Occupational Exposure/adverse effects*
;
Occupational Diseases/diagnosis*
;
Hazardous Substances
;
Neurotoxicity Syndromes/diagnosis*
;
Peripheral Nervous System Diseases
6.Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic.
SPECIALIZED COMMITTEE OF NEUROGENETICS NEUROPHYSICIAN BRANCH OF CHINESE MEDICAL DOCTOR ASSOCIATION ; Hong JIANG ; Beisha TANG
Chinese Journal of Medical Genetics 2020;37(4):359-366
Since December 2019, a series of highly infectious cases of unexplained pneumonia have been discovered in Wuhan, Hubei Province, which have been confirmed as '2019 corona virus disease' caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 virus can invade many human systems including the lungs. Patients with central nervous system involvement may show a series of neurological symptoms, which is easy to be misdiagnosed and neglected, thereby increasing the risk of SARS-CoV-2 transmission. Hereditary ataxia is a large group of neurodegenerative diseases with great clinical and genetic heterogeneity and high mortality and disability. In view of the seriousness of the COVID-19 epidemic, a series of prevention and control measures adopted by the government have restricted the follow-up, diagnosis and treatment of patients by the hospitals, which has a great impact on their mental and physical health. In order to standardize the management of patients during the prevention and control of COVID-19 epidemic, the Specialized Committee of Neurogenetics of the Neurophysician Branch of Chinese Medical Doctor Association has formulated this consensus, with an aim to help patients to overcome the difficulties and pass the epidemic prevention period safely.
Betacoronavirus
;
China
;
epidemiology
;
Consensus
;
Coronavirus Infections
;
complications
;
epidemiology
;
Epidemics
;
Health Status
;
Humans
;
Mental Health
;
Nervous System Diseases
;
virology
;
Pandemics
;
Pneumonia, Viral
;
complications
;
epidemiology
;
Spinocerebellar Degenerations
;
complications
;
diagnosis
;
prevention & control
;
therapy
7.Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease
Gregory VURTURE ; Benoit PEYRONNET ; Jose Alberto PALMA ; Rachael D SUSSMAN ; Dominique R MALACARNE ; Andrew FEIGIN ; Ricardo PALMEROLA ; Nirit ROSENBLUM ; Steven FRUCHT ; Horacio KAUFMANN ; Victor W NITTI ; Benjamin M BRUCKER
International Neurourology Journal 2019;23(3):211-218
PURPOSE: To assess the urodynamic findings in patients with Parkinson disease (PD) with overactive bladder symptoms. METHODS: We performed a retrospective chart review of all PD patients who were seen in an outpatient clinic for lower urinary tract symptoms (LUTS) between 2010 and 2017 in a single-institution. Only patients who complained of overactive bladder (OAB) symptoms and underwent a video-urodynamic study for these symptoms were included. We excluded patients with neurological disorders other than PD and patients with voiding LUTS but without OAB symptoms. RESULTS: We included 42 patients (29 men, 13 women, 74.5±8.1 years old). Seven patients (16.7%) had a postvoid residual (PVR) bladder volume >100 mL and only one reported incomplete bladder emptying. Detrusor overactivity (DO) was found in all 42 patients (100%) and was terminal in 19 (45.2%) and phasic in 22 patients (52.4%). Eighteen patients had detrusor underactivity (DU) (42.3%). Later age of PD diagnosis was the only parameter associated with DU (P=0.02). Patients with bladder outlet obstruction (BOO) were younger than patients without BOO (70.1 years vs. 76.5 years, P=0.004), had later first sensation of bladder filling (173.5 mL vs. 120.3 mL, P=0.02) and first involuntary detrusor contraction (226.4 mL vs. 130.4 mL, P=0.009). CONCLUSIONS: DO is almost universal in all patients with PD complaining of OAB symptoms (97.1%). However, a significant percentage of patients also had BOO (36.8%), DU (47%), and increased PVR (16.7%) indicating that neurogenic DO may not be the only cause of OAB symptoms in PD patients.
Ambulatory Care Facilities
;
Diagnosis
;
Female
;
Humans
;
Lower Urinary Tract Symptoms
;
Male
;
Nervous System Diseases
;
Parkinson Disease
;
Parkinsonian Disorders
;
Retrospective Studies
;
Sensation
;
Urinary Bladder
;
Urinary Bladder Neck Obstruction
;
Urinary Bladder, Overactive
;
Urinary Incontinence
;
Urodynamics
8.Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene Polymorphism
David AZOULAY ; Sami GIRYES ; Roni NASSER ; Rivka SHARON ; Netanel A HOROWITZ
Journal of Clinical Neurology 2019;15(4):511-516
BACKGROUND AND PURPOSE: Brain-derived neurotrophic factor (BDNF) is a neuronal growth factor that plays an essential role in the maintenance of the nervous system. We have evaluated the peripheral blood protein levels of BDNF and the valine-to-methionine substitution at codon 66 (Val66Met) single-nucleotide polymorphism (SNP) as potential biomarkers for the early recognition of chemotherapy-induced peripheral neuropathy (CIPN) in non-Hodgkin lymphoma and multiple myeloma patients. METHODS: CIPN was assessed in 45 patients at the diagnosis and during vincristine or bortezomib-based therapy using objective [reduced version of the Total Neuropathy Score (TNSr)] and subjective (FACT-GOG-NTx) tools. Depression was assessed using the Patient Health Questionnaire-9 (PHQ-9) questionnaire. BDNF protein levels and the Val66Met SNP were determined using ELISA and Sanger sequencing. RESULTS: The pretreatment BDNF protein level was inversely correlated with the maximum TNSr, FACT-GOG-NTx, and PHQ-9 scores in both genotypes. BDNF patients with the Val/Val genotype demonstrated significantly higher maximum FACT-GOG-NTx and PHQ-9 scores than those with the Val/Met and Met/Met genotypes (Met-BNDF carriers). Correlations between PHQ-9 and TNSr score were found only in Met-BDNF carriers, suggesting that peripheral neuropathy and depression coincide in Met-BDNF carriers. CONCLUSIONS: Determining the BDNF protein levels before initiating chemotherapy might be a useful tool for CIPN risk assessment and preemptive dose modification. The present data should be validated in larger studies that include other neurotoxic agents.
Biomarkers
;
Brain-Derived Neurotrophic Factor
;
Codon
;
Depression
;
Diagnosis
;
Drug Therapy
;
Enzyme-Linked Immunosorbent Assay
;
Genes, vif
;
Genotype
;
Humans
;
Lymphoma
;
Lymphoma, Non-Hodgkin
;
Multiple Myeloma
;
Nervous System
;
Neurons
;
Peripheral Nervous System Diseases
;
Risk Assessment
;
Vincristine
9.Clinical characteristics and management of patients with fat embolism syndrome in level I Apex Trauma Centre.
Richa AGGARWAL ; Arnab BANERJEE ; Kapil Dev SONI ; Atin KUMAR ; Anjan TRIKHA
Chinese Journal of Traumatology 2019;22(3):172-176
PURPOSE:
Fat embolism syndrome (FES) is systemic manifestation of fat emboli in the circulation seen mostly after long bone fractures. FES is considered a lethal complication of trauma. There are various case reports and series describing FES. Here we describe the clinical characteristics, management in ICU and outcome of these patients in level I trauma center in a span of 6 months.
METHODS:
In this prospective study, analysis of all the patients with FES admitted in our polytrauma intensive care unit (ICU) of level I trauma center over a period of 6 months (from August 2017 to January 2018) was done. Demographic data, clinical features, management in ICU and outcome were analyzed.
RESULTS:
We admitted 10 cases of FES. The mean age of patients was 31.2 years. The mean duration from time of injury to onset of symptoms was 56 h. All patients presented with hypoxemia and petechiae but central nervous system symptoms were present in 70% of patients. The mean duration of mechanical ventilation was 11.7 days and the mean length of ICU stay was 14.7 days. There was excellent recovery among patients with no neurological deficit.
CONCLUSION
FES is considered a lethal complication of trauma but timely management can result in favorable outcome. FES can occur even after fixation of the fracture. Hypoxia is the most common and earliest feature of FES followed by CNS manifestations. Any patient presenting with such symptoms should raise the suspicion of FES and mandate early ICU referral.
Adolescent
;
Adult
;
Central Nervous System Diseases
;
etiology
;
Early Diagnosis
;
Embolism, Fat
;
diagnosis
;
etiology
;
prevention & control
;
Fractures, Bone
;
complications
;
Humans
;
Hypoxia
;
etiology
;
Intensive Care Units
;
statistics & numerical data
;
Length of Stay
;
statistics & numerical data
;
Male
;
Patient Outcome Assessment
;
Time Factors
;
Trauma Centers
;
statistics & numerical data
;
Young Adult
10.Genetic analysis and prenatal diagnosis for a pedigree affected with X-linked Norrie disease.
Xinmiao YANG ; Wenwen LI ; Xueping SHEN ; Huifen SHAO ; Guosong SHEN
Chinese Journal of Medical Genetics 2019;36(5):462-464
OBJECTIVE:
To detect mutation of NDP gene in a pedigree affected with Norrie disease.
METHODS:
Sanger sequencing was used to analyze the NDP gene at Xp11.3. Prenatal diagnosis was performed on amniotic fluid sample after the causative gene was detected.
RESULTS:
Sanger sequencing has revealed a c.2T>C (p.M1T) missense mutation of the NDP gene in the proband and the fetus. The same variation was not found in ClinVar and HGMD database.
CONCLUSION
The c.2T>C mutation of the NDP gene probably underlies the Norrie disease in this pedigree.
Blindness
;
congenital
;
Eye Proteins
;
Female
;
Genetic Diseases, X-Linked
;
Humans
;
Nerve Tissue Proteins
;
Nervous System Diseases
;
Pedigree
;
Pregnancy
;
Prenatal Diagnosis
;
Retinal Degeneration
;
Spasms, Infantile

Result Analysis
Print
Save
E-mail